Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes

Journal of Endocrinological Investigation

Volumn 36, Issue 11, 2013, Pages 931-937

  Yuan, L ^a   Li, Y ^a,b   Li, G ^a   Song, Y ^a   Gong, X ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^c Hubei Provincial Academy of Preventive Medicine   (China)

Author keywords

cell function; Ang(1 7); Pancreatic microcirculation; Type 2 diabetic rats

Indexed keywords

ANGIOTENSIN[1-7]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; MALE; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INSULIN; ISLETS OF LANGERHANS; MALE; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PANCREAS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84891673212     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8951     Document Type: Article

References (29)

1. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell 2006, 10: 397-405.
2. Zanone MM, Favaro E, Camussi G. From endothelial to Beta cells: insights into pancreatic islet microendothelium. Curr Diabetes Rev 2008, 4: 1-9.
3. Li X, Zhang L, Meshinchi S, et al. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes 2006, 55: 2965-73.
4. Leung PS. Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes. Diabet Med 2007, 24: 110-6.
5. Shao J, Iwashita N, Ikeda F, et al. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun 2006, 344: 1224-33.
6. Younis F, Stern N, Limor R, Oron Y, Zangen S, Rosenthal T. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism 59: 1200-9.
7. Li X, Yuan L, Xu G, et al. Effect of renin angiotensin system blockade on the islet microvessel density of diabetic rats and its relationship with islet function. J Huazhong Univ Sci Technolog Med Sci 2009, 29: 684-8.
8. Yuan L, Li X, Xu GL, Qi CJ. Effects of renin-angiotensin system blockade on islet function in diabetic rats. J Endocrinol Invest 33: 13-9.
9. Yuan L, Li X, Li J, Li HL, Cheng SS. Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet. Acta Diabetol 2013. 50: 479-88.
10. Tikellis C, Cooper ME, Thomas MC. Role of the renin-angiotensin system in the endocrine pancreas: Implications for the development of diabetes. Int J Biochem Cell Biol 2006, 38: 737-51.
11. Zhang Y, Lu J, Shi J, et al. Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 2008, 42: 593-600.
12. Santos RA, Ferreira AJ, Simoes ESAC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008, 93: 519-27.
13. Peiro C, Vallejo S, Gembardt F, et al. Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J Hypertens 2007, 25: 2421-5.
14. Ferreira AJ, Santos RA. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 2005, 38: 499-507.
15. Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49: 1390-4.
16. Giani JF, Mayer MA, Munoz MC, et al. Chronic infusion of an-giotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009, 296: E262-71.
17. Shao Y, He M, Zhou L, Yao T, Huang Y, Lu LM. Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacol Sin 2008, 29: 829-37.
18. Benter IF, Yousif MH, Cojocel C, Al-Maghrebi M, Diz DI. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 2007, 292: H666-72.
19. Walter B, Bauer R, Gaser E, Zwiener U. Validation of the multiple colored microsphere technique for regional blood flow measurements in newborn piglets. Basic Res Cardiol 1997, 92: 191-200.
20. Hakkinen JP, Miller MW, Smith AH, Knight DR. Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc Res 1995, 29: 74-9.
21. Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998, 41: 127-33.
22. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004, 53: 989-97.
23. Hellman B, Jansson L, Dansk H, Grapengiesser E. Effects of external ATP on Ca(2+) signalling in endothelial cells isolated from mouse islets. Endocrine 2007, 32: 33-40.
24. Yoshitomi H, Zaret KS. Endothelial cell interactions initiate dorsal pancreas development by selectively inducing the transcription factor Ptf1a. Development 2004, 131: 807-17.
25. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO. Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology 2006, 147: 2315-24.
26. Johansson A, Lau J, Sandberg M, Borg LA, Magnusson PU, Carlsson PO. Endothelial cell signalling supports pancreatic beta cell function in the rat. Diabetologia 2009, 52: 2385-94.
27. Niu MJ, Yang JK, Lin SS, Ji XJ, Guo LM. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008, 34: 56-61.
28. Bindom SM, Hans CP, Xia H, Boulares AH, Lazartigues E. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 2010, 59: 2540-8.
29. Bindom SM, Lazartigues E. The sweeter side of ACE2: Physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009, 302: 193-202.